Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease
about
Antibiotic Complications During the Treatment of Mycobacterium ulcerans Disease in Australian Patients.Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer
P2860
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease
@ast
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease
@en
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease
@nl
type
label
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease
@ast
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease
@en
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease
@nl
prefLabel
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease
@ast
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease
@en
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease
@nl
P2093
P2860
P1476
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease
@en
P2093
Eric L Nuermberger
Jacques H Grosset
John Adamson
Paul J Converse
Sandeep Tyagi
Si-Yang Li
Yalan Xing
Yoshito Kishi
P2860
P304
P356
10.1371/JOURNAL.PNTD.0003823
P407
P577
2015-01-01T00:00:00Z